Combating Diseases with Computational Strategies Used for Drug Design and Discovery

被引:15
|
作者
Makhouri, Farahnaz R. [1 ]
Ghasemi, Jahan B. [2 ]
机构
[1] KN Toosi Univ Technol, Chem Dept, Fac Sci, Tehran, Iran
[2] Univ Tehran, Sch Sci, Analyt Chem Dept, Fac Chem, Tehran, Iran
关键词
Target identification; Lead discovery and optimization; Virtual screening; Virtual docking; QSAR; Pharmacophore mapping; In silico ADMET/PBPK prediction; DE-NOVO DESIGN; PROBABILISTIC NEURAL-NETWORKS; HUMAN INTESTINAL-ABSORPTION; SILICO TARGET PREDICTION; PROTEIN INVERSE DOCKING; IN-SILICO; REVERSE DOCKING; PHARMACOPHORE MODELS; SMALL-MOLECULE; GENOME-SCALE;
D O I
10.2174/1568026619666190121125106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Computer-aided drug discovery (CADD) tools have provided an effective way in the drug discovery pipeline for expediting of this long process and economizing the cost of research and development. Due to the dramatic increase in the availability of human proteins as drug targets and small molecule information due to the advances in bioinformatics, cheminformatics, genomics, proteomics, and structural information, the applicability of in silico drug discovery has been extended. Computational approaches have been used at almost all stages in the drug discovery pipeline including target identification and validation, lead discovery and optimization, and pharmacokinetic and toxicity profiles prediction. As each area covers a variety of computational methods, it is unmanageable to assess comprehensively all areas of CADD applications or every aspect of an area in one review article. However, in this article, we tried to present an overview of computational methods used in almost all the areas concerned with drug design and highlight some of the recent successes.
引用
收藏
页码:2743 / 2773
页数:31
相关论文
共 50 条
  • [1] Computational advances in combating colloidal aggregation in drug discovery
    Reker, Daniel
    Bernardes, Goncalo J. L.
    Rodrigues, Tiago
    NATURE CHEMISTRY, 2019, 11 (05) : 402 - 418
  • [2] Computational advances in combating colloidal aggregation in drug discovery
    Daniel Reker
    Gonçalo J. L. Bernardes
    Tiago Rodrigues
    Nature Chemistry, 2019, 11 : 402 - 418
  • [3] Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
    Munteanu, Cristian R.
    Fernandez-Blanco, Enrique
    Seoane, Jose A.
    Izquierdo-Novo, Pilar
    Angel Rodriguez-Fernandez, Jose
    Maria Prieto-Gonzalez, Jose
    Rabunal, Juan R.
    Pazos, Alejandro
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (24) : 2640 - 2655
  • [4] Computational drug discovery and design
    Anika, Mutia
    Ariyanto, Yogy Satria
    Gore, M.
    Jagtap, U. B.
    CRYSTALLOGRAPHY REVIEWS, 2023, 29 (04) : 247 - 250
  • [5] Drug Repurposing and Computational Drug Discovery: Strategies and Advances
    Khatami, Fajri
    Hairima, Hestia
    Fitria, Roudhotul
    CRYSTALLOGRAPHY REVIEWS, 2024,
  • [6] Computational Chemogenomics in Drug Design and Discovery
    Bisson, William H.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (17) : 1867 - 1868
  • [7] Computational Methods for Drug Discovery and Design
    Tropsha, Alexander
    Bajorath, Juergen
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 1 - 1
  • [8] Integration of target discovery, drug discovery and drug delivery: A review on computational strategies
    Duarte, Yorley
    Marquez-Miranda, Valeria
    Miossec, Matthieu J.
    Gonzalez-Nilo, Fernando
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2019, 11 (04)
  • [9] Techniques and Strategies in Drug Design and Discovery
    Nitulescu, George Mihai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [10] Computational strategies for design and discovery of nanostructured thermoelectrics
    Hao, Shiqiang
    Dravid, Vinayak P.
    Kanatzidis, Mercouri G.
    Wolverton, Christopher
    NPJ COMPUTATIONAL MATERIALS, 2019, 5 (1)